New drug BT-114143 passes first safety check in healthy volunteers
NCT ID NCT07169240
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This early-stage study tested the safety and how the body handles a single dose of BT-114143 in 84 healthy adults. Participants were randomly assigned to receive either the drug or a placebo, and no one knew who got which. The goal was to check for side effects and measure how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PKU Care Luzhong Hospital
Zibo, Shandong, 255499, China
Conditions
Explore the condition pages connected to this study.